Are Supply Chain Bottlenecks Impacting TPE Tubing Procurement?

Supply chain disruptions have become a persistent challenge for pharmaceutical procurement teams. Thermoplastic elastomer (TPE) tubing, a critical component in single-use bioprocessing systems, faces growing demand alongside increasing supply vulnerabilities. 

By Emily Newton 

Geographic concentration of production facilities, trade disruptions and fluctuating availability create procurement obstacles that can delay research timelines and compromise production schedules. Understanding these challenges and implementing strategic sourcing approaches can help procurement teams secure reliable access to the high-purity, chemically resistant tubing their applications require.

The Growing Challenge of Sourcing TPE Tubing in Pharma

The thermoplastic elastomer tubing market is experiencing consistent year-over-year growth, with projections indicating expansion from approximately $2.8 billion in 2023 to $5.4 billion by 2033. This surge reflects increasing adoption in pharmaceutical and bioprocessing applications.

However, production of critical pharmaceutical components remains geographically and industrially concentrated, creating vulnerabilities that ripple through global supply chains. Since a few pharmaceutical companies produce specific drugs, individual business decisions have widespread, prolonged effects on global availability.

Trade disruptions and fluctuating supply exacerbate these challenges, making reliable procurement increasingly difficult for pharmacists, biologists and life science professionals. However, TPE is still a superior tubing material for pharmaceutical applications.

TPE tubing offers several technical advantages that make securing a stable supply mission-critical:

●     High material purity: Nontoxic and latex-free formulations meet medical-grade application requirements.

●     Temperature versatility: Flexibility across broad temperature ranges enables diverse applications.

●     Cost efficiency: It’s generally more economical than silicone alternatives, making it ideal for high-volume, single-use applications.

●     Sterilization compatibility: It’s compatible with rigorous sterilization methods, including autoclave and gamma irradiation.

Strategies for Building a Resilient TPE Tubing Supply Chain

Mitigating these risks requires proactive supply chain strategies. Industry professionals can look to real-world case studies for insight.

Partnering With a One-Stop-Shop Supplier

A supplier with a broad portfolio and deep expertise reduces dependency on multiple vendors, simplifying procurement. With subject matter expertise and a broad portfolio of single-use tubing solutions, Sentinel Process Systems addresses pharmaceutical procurement challenges. Its approach emphasizes material purity, chemical resistance, weldability, sealability and regulatory compliance.

It helps customers quickly identify optimal products, and its expertise eliminates time spent evaluating specifications independently. This one-stop-shop model simplifies the procurement of single-use tubing solutions that meet USP Class VI and ISO 10993 biocompatibility standards, minimizing the administrative burden of managing multiple vendor relationships and purchase orders.

Taking Control With Vertical Integration

Companies that implement in-house manufacturing reduce dependency on external suppliers and become more resilient to supply chain disruptions. Venair's approach to single-use assemblies demonstrates this strategy in action. Through vertical integration, the company controls its manufacturing process from raw material sourcing through final assembly. This approach provides greater quality control, faster response times and reduced vulnerability to third-party supply interruptions.

Embracing Material Diversification

When suppliers offer diverse material options, procurement teams gain flexibility against single-material shortages. Freudenberg Medical's strategic expansion illustrates this approach. By diversifying its TPE tubing options, the company offers customers alternatives when specific formulations face availability constraints. Pharmaceutical manufacturers can pivot between materials without compromising application requirements or production timelines thanks to this diversification strategy.

Exploring Expanded Distribution Networks

Working with manufacturers who maintain strong, broad distribution partnerships improves accessibility and reduces lead times. The Teknor Apex and Nexeo partnership exemplifies this strategy. By establishing expanded distribution networks, the partnership increased TPE availability across North America. Broader distribution insulates procurement teams against regional supply disruptions and provides alternative sourcing channels when primary routes face delays.

Implementing a Closed-Loop Supply Chain

Forward-looking strategies, such as sustainability and recycling, also enhance supply resilience. DuPont's approach to implementing a closed-loop supply chain demonstrates the circular economy model. While the case study focuses on silicone, the principle applies equally to recyclable polymers like TPE. Reducing dependency on raw material supply chains enables closed-loop systems to support environmental objectives.

Frequently Asked Questions About TPE Tubing Procurement

Professionals should refer to these frequently asked questions for more insights.

What are the benefits of using TPE tubing over silicone?

Compared to silicone, TPE tubing offers superior abrasion, tearing and solvent resistance. Greater flexibility and softness make it easier to handle during assembly processes. Silicone materials often cost more to manufacture due to complicated raw material procurement and manufacturing processes, making TPE a more cost-effective choice for high-volume single-use applications. The cost differential becomes particularly significant in large-scale bioprocessing operations where single-use systems may require extensive tubing runs.

What is the chemical compatibility of TPE tubing?

With excellent chemical resistance to acids, bases and polar solvents, TPE tubing is ideal for sanitary fluid transfer in pharmaceutical applications. High compatibility with sealing and welding processes enables secure connections in single-use systems without compromising chemical integrity. This chemical resistance ensures that tubing maintains its structural integrity throughout process runs, preventing contamination and maintaining product purity.

What regulatory standards should TPE tubing meet?

TPE tubing for pharmaceutical applications should meet USP Class VI and ISO 10993 standards for biocompatibility of medical device materials. These certifications ensure the material is suitable for contact with biological fluids and tissues without causing adverse reactions. Compliance with these standards is essential for regulatory approval in pharmaceutical manufacturing and biopharmaceutical research applications.

Anticipating and Addressing Future Procurement Problems

A multifaceted strategy combining supplier partnerships, vertical integration, material diversification, expanded distribution networks and sustainable closed-loop systems provides the strongest defense against future supply chain disruptions.

No single approach eliminates all risk. However, procurement teams that implement multiple strategies simultaneously build resilience against the geographic concentration and trade vulnerabilities affecting the availability of thermoplastic elastomer tubing. Proactive planning ensures reliable access to the critical components that support research and production.

Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)